I am working on a new anti-vral drug which prevents viral attachment
successfully in HIV and RSV and a few others. For various reasons I am
looking to find out who is working on human heamorrhagic fevers as our lab
is not BSLIII or IV. Can anyone advise me on the possibility of having my
compound tested on Lassa, Ebola etc?
Thanks,
David Garnett
Lovesgrove Research limited
